HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

suplatast tosilate

structure given in first source; inhibits antigen-produced histamine release from mast cells; inhibits IgE antibody formation
Also Known As:
(2-(4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl)ethyl)dimethylsulfonium p-toluenesulfonate; IPD 1151T; IPD-1151T
Networked: 83 relevant articles (18 outcomes, 14 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yoshihara, Shigemi: 4 articles (06/2014 - 10/2007)
2. Arisaka, Osamu: 4 articles (06/2014 - 10/2007)
3. Fukuda, Hironobu: 3 articles (06/2014 - 08/2009)
4. Yamada, Yumi: 3 articles (06/2014 - 10/2007)
5. Yoshimura, Naoki: 3 articles (10/2007 - 05/2002)
6. Liu, Dan: 2 articles (07/2014 - 07/2013)
7. Li, Yun: 2 articles (07/2014 - 07/2013)
8. Ono, Mika: 2 articles (06/2014 - 08/2009)
9. Hashizume, Hideo: 2 articles (03/2014 - 09/2005)
10. Fujimura, Masaki: 2 articles (01/2008 - 01/2004)

Related Diseases

1. Asthma (Bronchial Asthma)
2. Inflammation
3. Atopic Dermatitis (Atopic Eczema)
4. Rhinitis
5. Cough

Related Drugs and Biologics

1. Interleukin-5 (Interleukin 5)
2. Prednisolone (Predate)
3. Immunoglobulin E (IgE)
4. Tacrolimus (Prograf)
5. Interleukin-4 (Interleukin 4)
6. Steroids
7. Interleukins
8. Enzymes
9. omalizumab (Xolair)
10. Eosinophil Cationic Protein

Related Therapies and Procedures

1. X-Ray Film
2. Aftercare (After-Treatment)
3. Oral Administration
4. Intraperitoneal Injections
5. Immunotherapy